Feature | Published:

Chasing a cellular fountain of youth

Nature Biotechnologyvolume 23pages807815 (2005) | Download Citation


  • An Erratum to this article was published on 01 October 2005

Biotech companies with business models as diverse as the products they are developing are laboring to move cell-based therapies into the clinic. Without a commercial success, however, investors will remain on the sidelines.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Dove, A. Cell-based therapies go live. Nat. Biotechnol. 20, 339–343 (2002).

  2. 2

    Bouchie, A. Tissue engineering firms go under. Nat. Biotechnol. 20, 1178–1179 (2002).

  3. 3

    Pearson, H. Early embryos fuel hopes for shortcut to stem-cell creation. Nature 432, 4 (2004).

  4. 4

    Keller, G. & Snodgrass, H.R. Human embryonic stem cells: the future is now. Nat. Med. 5, 151–152 (1999).

  5. 5

    Regalado, A. Big companies quietly pursue research on embryonic stem cells. The Wall Street Journal, April 12 (2005), p. A1.

  6. 6

    Louet, S. Reagent safety issues surface for cell/tissue therapies. Nat. Biotechnol. 22, 253–254 (2004).

  7. 7

    Keirstead, H. et al. Oligodendrocyte progenitor transplants and spinal cord injury. J. Neurosci. 25, 4766–4778 (2005).

  8. 8

    Bassett, P. Cell Therapy Technologies, Markets, & Opportunities (Drug & Market Development Publications, Westborough, Massachusetts, January, 2003). http://www.drugandmarket.com/9086

Download references

Author information

Author notes

  1. Ken Howard is a contributing writer based in Westborough, MA. Stephan Herrera is news editor at Nature Biotechnology, and Christopher Thomas Scott is a writer and author based in San Francisco, CA. His latest book, The Stem Cell, will be in bookstores September 1, 2005.


    1. Search for Ken Howard Wilan in:

    2. Search for Christopher Thomas Scott in:

    3. Search for Stephan Herrera in:

    Related links

    About this article

    Publication history

    Issue Date



    Further reading

    Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing